Reevaluation of the Microsomal Metabolism of Montelukast: Major Contribution by CYP2C8 at Clinically Relevant Concentrations-Reference-Cited by-同舟云学术

Reevaluation of the Microsomal Metabolism of Montelukast: Major Contribution by CYP2C8 at Clinically Relevant Concentrations

Published:2011-02-02 Issue:5 Volume:39 Page:904-911
ISSN:0090-9556
Container-title:Drug Metabolism and Disposition
language:en
Short-container-title:Drug Metab Dispos

Author:

Filppula Anne M.,Laitila Jouko,Neuvonen Pertti J.,Backman Janne T.

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmaceutical Science,Pharmacology

Reference36 articles.

1. CYP2C8 Activity Recovers within 96 Hours after Gemfibrozil Dosing: Estimation of CYP2C8 Half-Life Using Repaglinide as an in Vivo Probe

2. Gemfibrozil greatly increases plasma concentrations of cerivastatin

3. Metabolic profiles of montelukast sodium (Singulair), a potent cysteinyl leukotriene1 receptor antagonist, in human plasma and bile;Balani;Drug Metab Dispos,1997

4. Ketoconazole and sulphaphenazole as the respective selective inhibitors of P4503A and 2C9

5. Cytochrome P450 isoform inhibitors as a tool for the investigation of metabolic reactions catalyzed by human liver microsomes;Bourrié;J Pharmacol Exp Ther,1996

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enzyme-mediated drug-drug interactions: a review of in vivo and in vitro methodologies, regulatory guidance, and translation to the clinic;Drug Metabolism Reviews;2024-07-26

2. The Risk of Neuropsychiatric Adverse Events With Use of Leukotriene Receptor Antagonists in Patients With Asthma: Analysis of Korea’s National Health Insurance Sharing Service Database;The Journal of Allergy and Clinical Immunology: In Practice;2023-12

3. Application of reaction phenotyping to address pharmacokinetic variability in patient populations;Overcoming Obstacles in Drug Discovery and Development;2023

4. The mechanisms underlying montelukast's neuropsychiatric effects - new insights from a combined metabolic and multiomics approach;Life Sciences;2022-12

5. Leukotrienes vs. Montelukast—Activity, Metabolism, and Toxicity Hints for Repurposing;Pharmaceuticals;2022-08-23